USPTO serial 79025460
KRINGLE PHARMA INC.
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- YAO, GRETTA
- Law office
- TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with KRINGLE PHARMA INC.?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary and sanitary preparations; agents affecting nervous system; stimulants; antipyretic analgesics; anti-epileptics; analeptics; hypnotic sedatives; general anesthetics; anti-motion sickness agents; agents affecting peripheral nervous system; local anesthetics; skeletal muscle relaxants; anhidrotics; autonomics; antispasmodics; diaphoretics; agents affecting sensory organs; agents for ophthalmic use; agents for otic and nasal use; antiallergic agents; antihistaminics; agents for stimulation therapy; cardiovascular agents; cardiotonics; antihypertensives; vasoconstrictors; capillary stabilizers; cerebral hemorrhage prophylactic agents; antiarrhythmic agents; diuretics; agents affecting respiratory organs; respiratory stimulants; anti-cough drops; antitussive expectorants; agents affecting digestive organs; gastrointestinal cleaning agents; clysters; evacuants (purgatives); stomachics and digestives; agents for oral use; emetics; medicines for dental purposes; antacids; intestinal regulators; antiemetics; castor oil (for medical purposes); cholagogues; hormones for medical purposes; thyroid and para-thyroid hormone preparations; mixed hormone preparations; estrogen preparations; pancreas hormone preparations; salivary gland hormone preparations; androgen preparations; pituitary hormone preparations; adrenal hormone preparations; agents for uro-genital and anal organs; oxytocics; anti-hemorrhoidals; emmenagogues; contraceptives (preparation); agents for epidermis; pharmaceutical preparations for purulence; anti-dermoinfectives; antimicrobials for dermatologic use; astringents (pharmaceutical); anti-inflammatory agents; analgesics; anti-itchings; talcum powder; emollients; hair remedies; medicated baby oils; medicated baby powders; medicated bath preparations; vitamin preparations; cod-liver oil drops; mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations; threonine preparations; tryptophane preparations; methionine preparations; lysine preparations; royal jelly (for medical purposes); calcium supplements; chondroitin preparations; organotherapeutics; protein and amino acid preparations; saccharide preparations; mineral preparations; medicinal alcoholic beverages; organic acid preparations; anticoagulants; blood substitutes; blood plasma; hemostatics; agents affecting metabolism; antidotes; enzyme preparations for medical purposes; lactagogues; lipotropic factor preparations; agents for habitual intoxication; cellular function activating agents; tumor suppressing agents; anti-cancer preparations; anti-sarcoma preparations; agents for treating physically caused lesions; heatstroke treating agents; radiation sickness treating drugs; agents for treating chemically caused disorders; chlorine-detoxication agents; arsenic-detoxication agents; benzol-detoxication agents; antibiotic preparations; erythromycin preparations; chloramphenicol preparations; colistin-polymixin preparations; salkomycin preparations; streptomycin preparations; thiolutin preparations; tetracycline preparations; trichomycin preparations; mixed antibiotic preparations; penicillin preparations; chemotherapeutics; antisyphilitics; antituberculous agents; sulfonamide preparations; antileprotic agents; biological preparations for medical purposes; antitoxic sera; antitoxins; mixed biological preparations; preparations for biological tests; toxoids; toxins; vaccines; agents against parasites; anthelmintics; antiprotozoadn agents; agents for dispensing purposes; odor improving agents for drugs; flavoring agents for drugs; coloring agents (for drugs); ointment bases for drugs; excipients; solvents for drugs; diagnostic preparations; X-ray contrast agents; diagnostic reagents; diagnostic media for bacteriological cultures; radio-isotope markers for therapeutic or diagnostic use; narcotics; opium alkaloid preparations; synthetic narcotics; coca alkaloid preparations; crude drugs; charred drugs and moxa; veterinary preparations; mosquito-repellent incenses; germicides and fungicides; rodenticides; insecticides; fumigants; herbicides (weedkillers); deodorants(other than for personal use); insect-repellents; antiseptics | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 15, 2016 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| Jun 18, 2016 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jun 17, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 31, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 24, 2008 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 7, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 7, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 17, 2008 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 3, 2008 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 3, 2008 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 3, 2007 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 3, 2007 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 22, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 7, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 22, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 22, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 17, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 16, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Aug 3, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |